ArticleHematology, transfusion and cell therapy

A real life use of ruxolitinib in patients with acute and chronic graft versus host disease refractory to corticosteroid treatment in Latin American patients.

Mauricio Sarmiento et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.